A Comparative Clinical Research on Single Roux-en-Y and Traditional Roux-en-Y of Pancreaticojejunostomy-choledochojejunostomy For Treatment of Obstruction of Pancreatic Duct and Bile Duct

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT01926717

Enrollment

100

Registered

2013-08-21

Start date

2010-12-31

Completion date

2018-12-31

Last updated

2016-03-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pancreatic Cancer

Keywords

Single Roux-y of Pancreaticojejunostomy-choledochojejunostomy

Brief summary

This study is being done to learn more about how different surgery procedures bring back the quality of life.After removing the small intestine at least 20cm in patients with pancreatic cancer, Some patients develop problems because they are disorder their digestive system, such as cramping, heartburn,vomiting.

Interventions

None listed

Study design

Observational model

CASE_CONTROL

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

30 Years to 70 Years

Healthy volunteers

Inclusion criteria

* Patient 30 years of age or older * Pathologically confirmed pancreatic cancer (biopsy may be performed at our institution) * No evidence of metastases(a) * decide performe Roux-en-Y(b) * single Roux-en-Y reconstruction is technically feasible(c) * Patients will be registered and consent obtained, if the surgeon believes there is no evidence of metastases. If metastatic disease is identified at the time of operation, the patient will not be randomized. * Patients will be conditionally enrolled, and consent obtained, if the surgeon believes the patient may need a sngle Roux-en-Y at the time of operation. If a sngle Roux-en-Y is not performed, the patient will not be randomized. * the surgeon feels that the single Roux-en-Y is not technically feasible at the time of operation,the patients will be excluded. This may be due to prior abdominal surgery, anatomic variants, or anything else at the surgeon's discretion.

Exclusion criteria

* Not expected to be able to provide follow-up over 2 years (due to geographic or other limitations)

Design outcomes

Primary

Measure	Time frame
The secretion function of the pancreas	Participants will be followed for overall 3 year after surgery

Secondary

Measure	Time frame
The function of biliary tract	Participants will be followed for overall 3 year after surgery

Other

Measure	Time frame
The relief of abdominal pain symptom	Participants will be followed for overall 3 year after surgery

Countries

China

Outcome results